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Abstract
Background
Neglected Tropical Diseases (NTDs) not only cause health and life expectancy loss, but
can also lead to economic consequences including reduced ability to work. This article
describes a systematic literature review of the effect on the economic productivity of individ-
uals affected by one of the five worldwide most prevalent NTDs: lymphatic filariasis, oncho-
cerciasis, schistosomiasis, soil-transmitted helminths (ascariasis, trichuriasis, and
hookworm infection) and trachoma. These diseases are eligible to preventive chemother-
apy (PCT).
Methodology/Principal Findings
Eleven bibliographic databases were searched using different names of all NTDs and vari-
ous keywords relating to productivity. Additional references were identified through refer-
ence lists from relevant papers. Of the 5316 unique publications found in the database
searches, thirteen papers were identified for lymphatic filariasis, ten for onchocerciasis,
eleven for schistosomiasis, six for soil-transmitted helminths and three for trachoma.
Besides the scarcity in publications reporting the degree of productivity loss, this review
revealed large variation in the estimated productivity loss related to these NTDs.
Conclusions
It is clear that productivity is affected by NTDs, although the actual impact depends on the
type and severity of the NTD as well as on the context where the disease occurs. The larg-
est impact on productivity loss of individuals affected by one of these diseases seems to be
due to blindness from onchocerciasis and severe schistosomiasis manifestations; produc-
tivity loss due to trachoma-related blindness has never been studied directly. However,
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productivity loss at an individual level might differ from productivity loss at a population level
because of differences in the prevalence of NTDs. Variation in estimated productivity loss
between and within diseases is caused by differences in research methods and setting.
Publications should provide enough information to enable readers to assess the quality and
relevance of the study for their purposes.
Author Summary
Neglected Tropical Diseases (NTDs) not only have impact on health and life expectancy of
mostly disadvantaged populations, but can also lead to economic consequences, including
reduced ability to work. Investments in health improvement of the populations affected by
NTDs would also help to increase economic growth of the affected regions, since healthier
populations are more economically productive. We performed a systematic literature
review to better understand how much NTDs affect people’s economic welfare. Here we
present the results for the NTDs that are controlled with preventive chemotherapy (PCT):
lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminths (ascariasis,
trichuriasis, and hookworm infection) and trachoma. Our findings show that PCT NTDs
clearly affect productivity, although the actual impact depends on the type and severity of
the NTD as well as on the context where the disease occurs. Variation in estimated pro-
ductivity loss is also caused by differences in research methods. Publications should pro-
vide enough information to enable readers to assess the quality and relevance of the study
for their purposes.
Introduction
Most of the people affected by Neglected Tropical Diseases (NTDs) are impoverished and mar-
ginalized populations, with low visibility and little political voice. They are not considered a
priority market for pharmaceutical manufacturers or a health risk for the wealthier parts of the
world. [1–3] Nevertheless, NTDs have an important impact on child development, school
attendance, learning, nutritional status, pregnancy outcomes, and worker productivity, espe-
cially in poor rural settings, where physical labor is the major subsistence mode. As any other
disease, they can lead to productivity loss in many ways, including reduced productivity at
work (presenteeism), absence from work (absenteeism) or even job loss, depending on the
type, severity and duration of the disease. [2–12]
Many publications in the literature describe the epidemiological and physical aspects of
NTDs. In contrast, the impact of NTDs on paid and unpaid work and the productivity of indi-
vidual men and women has been less frequently studied. Most of the data about the economic
burden of NTDs come from small studies in restricted geographical areas.[13]
The costs of treatment, mainly long-term ones, can inflict further economic difficulties in
populations already struggling to live with less than US$ 1 a day. Besides the obvious advan-
tages of decreasing the healthcare costs due to lack of care or delayed care, investments in
health improvement would also help to increase economic growth of the affected regions since
healthier populations are more economically productive. [14–16]
As part of the movement to increase the attention given to NTDs, a coalition of many stake-
holders gathered in January 2012 to discuss the importance of reaching the 2020 WHO goals
for this group of diseases. As a result, the London Declaration was signed by many partners,
committed to eradicate Guinea worm disease, eliminate three NTDs (lymphatic filariasis,
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leprosy, African sleeping sickness (human African trypanosomiasis) and blinding trachoma)
and control the others (schistosomiasis, soil-transmitted helminths, Chagas disease, visceral
leishmaniasis and river blindness (onchocerciasis)). [17,18]
A better understanding of the effect that NTD have on people’s economic livelihood would
be an additional argument in favor of controlling or eliminating them. With this in mind, we
performed a systematic literature review to identify and examine publications describing the
impact of the London Declaration NTDs. Here we present the results for the five most preva-
lent ones, which are the ones eligible for preventive chemotherapy (PCT diseases): lymphatic
filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminths (ascariasis, trichuriasis,
and hookworm infection) and trachoma on productivity loss in adults. [7,19,20]
Methods
We performed a comprehensive search of the literature relating to the economic impact of all
of the NTDs included in the London Declaration. Databases searched included Embase, Med-
line (OvidSp), Web of Science, Scopus, CINAHL, PubMed publisher, Cochrane, Popline,
Lilacs, Scielo and Google Scholar. The search terms aimed at identifying articles about direct
costs of treatment (such as consultation fees, medication, transport, food, assistance, accom-
modation), as well as indirect labor costs arising from decreased working hours and reduced
economic activity attributable to morbidity. The search strategy included the names of the ten
London Declaration NTDs (since many articles mention more than one) and words such as:
‘economic', 'financ', 'cost', 'productivity', 'absenteeism', 'employment', and 'cost'. A detailed list
of the keywords used for each database is found in Supporting Information (S1 File). The
search only considered title and abstracts, did not use any time restriction, and was restricted
to the English language. The main database search was conducted in November 2013. There is
no review protocol registered. This search included not only productivity loss, but also direct
costs for all 10 London Declaration NTDs for a larger project. The results found in this article
are limited to the results of the literature search regarding productivity loss from PCT NTDs.
The databases were merged according to the order shown in Table 1. Duplicates were
removed automatically using Endnote and the remaining articles were then compared manu-
ally using author, year, title, journal, volume and pages to identify any additional duplicates.
[21] After duplicates were excluded, we selected the articles that were related to each particular
disease and screened the abstract and title of all papers to identify the ones that might provide
information on productivity or indirect costs. The full-text versions of all remaining articles
Table 1. Results of database searches.
Database Hits After exclusion of duplicates
Embase.com 2913 2854
Medline (OvidSP) 2887 682
Web-of-science 1224 478
Scopus 3339 660
CINAHL 282 126
PubMed publisher 175 150
Cochrane 60 7
Popline 176 147
Lilacs 257 100
Scielo 36 26
Google Scholar 100 87
Total 11449 5316
doi:10.1371/journal.pntd.0004397.t001
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were then examined. Articles that did not contain any information on productivity, or only
qualitative information on productivity loss (without any quantitative measures) were
excluded, as well as articles that investigated productivity loss in children. Since the number of
relevant publications was expected to be small, no restrictions were made regarding popula-
tions (participants), interventions, comparisons, outcomes, study design, or length of follow-
up. Articles that could not be retrieved through their respective journals, contacting libraries,
or after contacting the authors were classified as ‘not available’ and excluded from the selection.
Any additional relevant articles identified when reading the full-text articles or checking their
reference lists (i.e., the ‘snowball’ search strategy) were screened using abstract and title and
then examined in more detail if they were considered potentially relevant.
In addition to searches using databases relating to the ‘white’ literature, we also searched the
grey literature by screening websites of relevant organizations (i.e. World Health Organization,
the Centre for Neglected Tropical Diseases, the Carter Center) (see S2 File). The list of selected
articles for each disease was sent to disease experts identified in the literature and from institu-
tions researching/combating NTDs, to check if the selection was comprehensive.
Data were extracted from selected articles independently, using a standardized Excel sheet,
for the variables: author, year, study design, population, sample size, follow-up period, country,
region, disease sequela, definition of productivity loss and results. Disease sequelae are disease
manifestations, which for this review were defined by the Global Burden of Disease 2010 study
(see S1 Table). [22] No summary measure was chosen beforehand. Instead, the results were
presented separately per disease and study and described as they were reported in the articles;
results were not statistically combined.
If the productivity loss was not already described in percentages of annual productivity in
the articles, we calculated it whenever the unit of measurement made it possible, for the sake of
comparability between studies and diseases. A working year was assumed to consist of 300
working days. [23]
Since the outcome of interest was productivity loss, various study designs were expected.
The studies were therefore critically appraised regarding general criteria of selection, perfor-
mance, attrition, detection, and reporting biases, as specified in the Cochrane Handbook for
Systematic Reviews of Interventions. [24,25] Therefore, each article was given a rating regard-
ing the risk of bias (possible options: low, high or unclear) for each criterion as well as a sum-
mary rating. [24,25] We added an extra criterion about the degree of relevance that the study
outcomes defined as productivity loss had in terms of quantifying productivity loss in adults
due to an NTD. This ‘relevance’ criterion was also rated as low or high. This review was con-
ducted according to the PRISMA checklist for systematic reviews.
Results
Results of the database searches
Table 1 provides an overview of the databases searched and the number of articles identified
through each of them. In total, 11,449 articles regarding all 10 NTDs were identified using the
database searches. Of these, 5,316 articles remained after duplicates were removed. There was
no duplication across the various NTDs.
Lymphatic filariasis. From the main database, 281 peer reviewed papers were related to
lymphatic filariasis (LF). The grey literature search and snowballing method added 24 more
articles, resulting in 305 articles being screened by title and abstract. Of the 72 full-text publica-
tions that were examined, 13 quantitatively described productivity loss related to LF (S1 Fig).
Lymphedema and hydrocele due to lymphatic filariasis are the two sequelae considered by
the GBD study for this disease. Acute dermatolymphangioadenitis (ADLA) is part of these
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sequelae as acute inflammatory attacks suffered by most of the chronic patients, sometimes
many times a year.[23]
An overview of the studies that used a quantitative method to describe productivity loss
from lymphatic filariasis can be seen in Table 2, together with the calculated percentages of
productivity loss.
Productivity loss in LF patients can occur because of ADLA or the chronic sequelae of the
disease (lymphedema and hydrocele). Our search identified six studies that examined only the
acute attacks (ADLA), five articles that described the impact of chronic sequelae, and two that
measured both.
The range in estimated productivity loss during ADLA attacks was 77–100% during the
days of the attacks. The ranges in annual productivity loss reported in the literature were 10–
26% for lymphedema and 15–19% for hydrocele (only the chronic sequelae). However, studies
of productivity loss due to lymphedema and hydrocele rarely considered the different stages
and varying severity of these symptoms. Most of the studies describing productivity loss due to
LF measured it by comparing lost working hours or days amongst workers with LF with those
seen amongst healthy workers.
Onchocerciasis. Of the 5316 articles in the source database, only 167 articles were related
to onchocerciasis. In addition, 52 articles were found through the ‘snowball’ search and grey lit-
erature sources, which meant that a total of 219 articles were screened on abstract and title. Of
these, 57 articles remained for full-text examination; from which only 10 contained quantita-
tive information on productivity losses related to onchocerciasis (S2 Fig).
The GBD sequelae (disease manifestations) considered for onchocerciasis were skin disease
and vision loss.
Table 3 provides an overview of studies that have quantitatively examined productivity loss
resulting from onchocerciasis. Only one study—by Thomson—reported productivity loss due
to onchocerciasis in general, of 20%.[26] The other papers focused on the effects of the specific
sequelae of onchocerciasis on productivity.
Four studies examined productivity loss related to onchocerciasis skin disease (OSD) [27–
30]. Two of these studies compared Ethiopian coffee plantation workers with OSD to unin-
fected workers at the same plantation: Workneh et al.[29] concluded that workers with OSD
had a one-year income that was 25% lower than that of healthy workers while Kim et al. [28]
found 10–15% lower daily wages of individuals with OSD compared to those without. The
study by Oladepo et al. [27] focused on the utilization of land and found that men with OSD
had a significantly smaller (34%) amount of land than men without OSD. The study by the
World Bank [30] found that individuals with onchocerciasis spent less time per day performing
productive activities (farming and non-farming) and household activities than healthy individ-
uals. However, these differences were not statistically significant.
Evans (1995) discussed the economic impact of blinding onchocerciasis [31], and found
that visual acuity was strongly associated with occupational status. Approximately 80% of peo-
ple that were blind due to onchocerciasis did not work, compared to 60% of the visually
impaired (due to onchocerciasis) and 2% of the sighted.
Three studies (Thomson [26]; Wogu et al. [32] and Okeibunor et al. [33]) described in more
general terms the socioeconomic consequences of onchocerciasis. For instance, Wogu et al.
[32] reported that 13.5% of individuals with onchocerciasis-related itching experienced
reduced concentration at work. In addition, 14% of the individuals with ocular lesion reported
that they gave up their jobs because of visual impairment. Similarly, Okeibunor et al. [33]
found that 76% of their subjects reporting increased productivity after (community based)
treatment with ivermectin.
Systematic Review on Productivity Loss Caused by NTDs
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004397 February 18, 2016 5 / 19
Table 2. Description of studies investigating productivity loss due to lymphatic filariasis.
Author Year Country Study
design
Population Sample
size
Definition of
productivity
loss
Sequela Results Adjusted
percentage
of prod.
loss 1
Babu 2002 India Case vs
control
Small farmers,
daily wage
laborers
377 Working hours/
day
a) chronic
filariasis (both
sequelae)
a) 4.94 ± 3.33 vs
6.06 ± 3.22
controls
a) 18.48%
(annual)
b)
lymphedema
b) male
4.45 ± 3.52 vs.
5.26 ± 3.21
controls (not
significant) /
female 5.45 ± 3.3
vs.7.12 ± 3.07
controls
b) male
15.40%
(annual) /
female
23.45%
(annual)
c) hydrocele c) 4.98 ± 3.00 vs.
5.78 ± 2.84
controls
c) 13.84%
(annual)
Babu 2003 India Case vs
control
Small farmers,
daily wage
laborers
1329 Hours spent in
economic
activity
ADLA 0.81 ± 2.31 h/day
ADLA vs.
3.50 ± 3.74 h/day
controls
76.85%
(during ADLA
episode)
1.58%
(annual)
Babu 2006 India Case vs
control
Weavers 136 Hours spent in
productive work/
day
a)
lymphedema
a) 8.02 ± 2.67 vs.
9.13 ± 1.61
controls
a) 10%
(annual)
b) hydrocele b) 8.71 ± 1.86 vs.
10.08 ± 1.70
controls
b) 18.9%
(annual)
Budge 2013 India Pre/post-
intervention
Homemakers/
Housekeepers
375 Working days
lost to disability
in the previous
30 days
Lymphedema 6.4 days 21.3%
(annual)
Chandrasena 2004 Sri
Lanka
Cohort Patients
attending
morbidity
control clinics
31 Capacity to
perform any
domestic or
economic
activity
ADLA 52% totally /
31.3% moderately
incapacitated
during ADLA
episode
1.53%
(annual)2
Chu 2010 Review Review Review Review Reduced work
hours and
economic
activity
a) ADLA a) 75% during
ADLA episode
Idem
b)
lymphedema
b) 20% b) 22.56%
(annual)3
c) hydrocele c) 15% c) 20.41%
(annual)3
Gasarasi 2000 Tanzania Cohort Three villages
in Rufiji district
65 Total
incapacitation
due to ADLA
ADLA 72.5% of the
episodes, mean
duration of 3.7
days
0.9% (annual)
Gyapong 1996 Ghana Case vs
control
Subsistence
farmers
572 Ability to
perform
activities (vs
others with
similar
diseases)
ADLA at least 3 full days
of incapacitation
at least 1%
(annual)
Ramaiah 2000 India Case vs
control
Agricultural
workers,
carpenters,
weavers
263
ADLA
478 Lym
Time spent on
economic
activity/day
a) ADLA a) 0.97 ± 2.36 h/
day vs. 4.48 ± 3.82
controls during
attacks
a) 78.34%
during ADLA
episode
(Continued)
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In addition to the observational studies of onchocerciasis-related productivity loss, we also
identified several economic evaluations that considered productivity loss in their analyses. Two
cost-benefit analyses, one by Benton and another by Kim, included productivity gains due to
prevention of onchocerciasis blindness as part of the benefits of prevention. [34,35]. However,
these gains were not actually observed in a patient population but based on the assumption
that blind individuals are not productive at all. Kim et al. [35] assumed that each prevented
case of blindness would result in 20 years of extra productivity.
Schistosomiasis. From the main search database, 670 articles referred to schistosomiasis,
including publications identified through ‘snowball’ searching and grey literature sources. Of
these, 26 articles were retrieved for full-text examination and eleven of them contained quanti-
tative information on productivity losses caused by schistosomiasis (S3 Fig).
Three different worms of the genus Schistosoma can cause schistosomiasis: Schistosoma
haematobium, Schistosoma mansoni, and Schistosoma japonicum. Ten sequelae were included
for schistosomiasis in the GBD study: mild diarrhea, mild anemia, moderate anemia, severe
anemia, hepatomegaly, hematemesis, ascites, dysuria, bladder pathology, and hydronephrosis
due to schistosomiasis.
Table 2. (Continued)
Author Year Country Study
design
Population Sample
size
Definition of
productivity
loss
Sequela Results Adjusted
percentage
of prod.
loss 1
b)
lymphedema
b) 4.40 ± 3.79 h/
day vs. 5.13 ± 3.83
controls
b)14.23%
(annual),
24.3%
(annual)3
Ramaiah 1999 India Case vs
control
Agricultural
workers,
carpenters,
weavers
150 Time spent on
economic
activity/day
a)
lymphedema
a) 3.93 h vs. 4.64
h controls
a) 15.3%
(annual)
b) hydrocele b) 5.10 h vs 6.19 h
controls
b) 17.6%
(annual)
Ramaiah 1998 India Case vs
control
Two villages
(south India)
124 Working hours ADLA 0.68 ± 1.91h vs
4.40 ± 3.74 h
controls /
3.58 ± 1.95 days
duration/attack
84.54% during
ADLA episode
/ 1% (annual)
Ramaiah 1997 India Case vs
control
Agricultural
workers,
weavers
372 Working hours ADLA,
lymphedema,
hydrocele
28% worked fewer
hours, 5% gave up
work
4
Sabesan 1992 India Case vs
control
Patients
attending
filariasis clinics
528 Working days ADLA a) 23.4 days/year
Bancroftian
filariasis
a) 7.8%
(annual)
b) 26.5 days/year
Brugian filariasis
b) 8.8%
(annual)
ADLA—acute dermatolymphangioadenitis
1. Translation into percentage of productivity loss as described in the cited source, assuming 300 working days a year, for the ADLA episodes alone, for
chronic sequelae alone, or for the weighted average of both, when applicable.
2. Totally incapacitated assumed 100% productivity loss, moderately incapacitated assumed 50% productivity loss during ADLA episodes
3. Weighted average including productivity loss from ADLA episodes and chronic symptoms
4. Only qualitative data, impossible to calculate annual productivity loss.
doi:10.1371/journal.pntd.0004397.t002
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Table 3. Description of studies investigating productivity loss due to onchocerciasis.
Author Year Country Study design Population Sample
size
Sequela Definition of
productivity loss
Results 1
Benton 1990 World CBA/model n/a n/a Blindness Assumption 100%
Evans 1995 Guinea -OCP
area
Observational
(survey)
Household members
in a highly endemic
area
319 a) visual
impairment
Self-reported 'inactive'
occupational status
a) 38%
b) blindness b) 79%
Kim 1995 West Africa CBA/model n/a n/a Blindness a) Productive years
gained by preventing
onchocerciasis
blindness
a) 20 years
b) Potential productivity
loss
b) 100%
Kim 1997 Ethiopia Case vs. control Coffee plantation
workers
235 a) OSD—
intermediate
Daily wages (individuals
infected with OSD vs.
those without)
a) 10%
b) OSD—severe Daily wages (individuals
infected with OSD vs.
those without)
b) 15%
Okeibunor 2011 Cameroon,
DRC, Nigeria,
Uganda
Observational
(cross sectional)
Primarily residents
from villages where
ivermectin distribution
was ongoing
1600 General
onchocerciasis
a) Increase in
productivity from
ivermectin treatment
a) 76%
b) Percentage of
respondents that
referred ability to work
better after ivermectin
treatment
b) (75.6%)
Oladepo 1993 Nigeria Case vs. control Male farmers 102 OSD Farm size that a men
can keep satisfactorily
weeded (workers with
vs. without OSD)
9,117 vs
13,850 m2
(34% loss)
Thomson 1971 Cameroon Case vs. control Estate workers in an
onchocerciasis
endemic area
420 Unspecified
(general)
Working days (workers
with vs. without
onchocerciasis)
20%
Wogu 2008 Nigeria Observational
(survey)
Rural farming
community in a meso-
endemic area
200 a) OSD—itching a) Percentage of
respondents that
referred reduction in
strength and
concentration at work
a) 13.5%
b) OSD—
nodules
b) Percentage of
respondents that
referred decline in sales
in business/trading
b) 11%
c) visual
impairment–
ocular lesions
c) Percentage of
respondents that
reported giving up jobs
(Productivity loss not
specified)
c)14%
Workneh 1993 Ethiopia Case vs. control Male permanent
coffee plantation
workers
196 OSD Absenteeism/sick leave
and net monthly pay
(workers with vs. without
OSD)
25%
World
Bank
1997 Nigeria,
Ethiopia,
Sudan
Case vs. control Households in
hyperendemic
communities
824 OSD Time spent on
productive activities
(individuals with vs.
without OSD signs and
symptoms)
not
significant
CBA—cost-benefit analysis; OSD—onchocerciasis skin disease; n/a—not applicable
1. Percentage of annual productivity loss already calculated in the original publication
doi:10.1371/journal.pntd.0004397.t003
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Table 4 provides a list of the studies investigating productivity loss attributable to schistoso-
miasis and the calculated percentages of annual productivity loss.
The studies vary regarding schistosomiasis being caused by S. haematobium, S.mansoni or
S. japonica and also regarding the sequela they focused on. Most of the studies we identified
compared productivity loss between infected and uninfected workers in a company or munici-
pality, whereas Blas et al. and Wright et al. calculated the costs of productivity loss based on
assumptions and not on empirical data. [36,37] Productivity loss was also measured using dif-
ferent units: lost man-days/work days [38–41], reduced earnings/bonus/incentives [42–44],
cane cut [45], and lost working hours [43].
Soil-transmitted helminths. In total, 538 articles in the source database were related to
soil-transmitted helminths (STH)(ascariasis, trichuriasis and hookworm disease). The snow-
balling method and the gray literature search yielded an additional 48 articles, which meant
that 586 articles were screened by title and abstract. Of the 72 publications that were fully read,
only 6 had information related to productivity loss and STH (S4 Fig).
The GBD study lists the following sequelae related to each of the STH diseases: infestation,
severe wasting, and mild abdominopelvic problems, as well as anemia only for hookworm
disease.
Table 5 shows the list of studies, the summary of their findings regarding productivity loss
as a consequence of STH, and the yearly percentages that were calculated wherever needed.
Productivity loss from STH infection was generally measured by comparing infected to
uninfected controls. Wolgemuth et al. observed that road construction workers with infection
showed 6% less productivity (measured using volume of earth moved) than other workers. [46]
Tanner et al. compared the agricultural and hunting or fishing yields reported in a 24-hour
period among an indigenous Amazonian group of hunter–horticulturalists. There was a nega-
tive association of hookworm infection for both women and men, with hookworm-infected
people reporting an average quantity of crops that was 35.29% less than uninfected people (no
statistical significance). [47]
Productivity loss associated with anemia was mostly measured in women with three studies,
by Casey et al., Gilgen et al., and Selvaratnam et al. [48–50] One study by Basta et al. investi-
gated men [51] and one byWolgemuth et al. investigated both women and men.[46] Two stud-
ies compared anemic versus non-anemic workers—Basta, and Gilgen [51,52], while three
studies examined the productivity of the same individual twice, once while anemic and infected
by STH and once after an intervention to increase the hemoglobin level—Casey, Selvaratnam,
Wolgemuth [46,48,50], with or without deworming. The only randomized controlled trial was
performed by Gilgen et al., assessing iron supplementation with and without deworming, with
a significant negative association between hookworm infection and ferritin levels. Furthermore,
anemic workers had a poorer performance regarding kilograms of leaves plucked and wages
earned by day, as well as more sick and absent days compared to non-anemic workers. [52]
There were two studies describing a positive linear association between hemoglobin and pro-
ductivity. Selvaratnam et al found that an increase in 1g/dL in hemoglobin corresponded with
an increase in 26% in a worker’s productivity. [50] Wolgemuth et al. described a linear increase
in productivity ranging from 3.5% to 5.6% (depending on the formula used in the study) for
each 1g/L in hemoglobin gain.[46]
Trachoma. In total, 538 articles from the initial search were related to trachoma and 11
articles were found through the ‘snowball’ search and grey literature sources, which led to a
sum of 549 articles that were screened on title and abstract. Of these, 22 articles remained for
full-text examination (S5 Fig).
The only sequela considered by the GBD study for trachoma was vision loss (from low
vision to blindness).
Systematic Review on Productivity Loss Caused by NTDs
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004397 February 18, 2016 9 / 19
Table 4. Description of studies investigating productivity loss due to schistosomiasis.
Author Year Country Study design Population Sample size Sequela Definition of
productivity
loss
Results Percentage
of annual
prod. loss 1
Audibert 1998 Mali Case vs.
control
Families
cultivating paddy
in endemic
region treated
and not treated
with
praziquantel
412
households
infection by S.
haematobium;
S. mansoni
a) man-days
worked/ha
a) 69 man-
days per
family worker
a) 23%
b) farm size b) additional
0.47 ha
b) 8.7%
Barbosa 1981 Brazil Retrospective
study
+ prospective
study (both
observational;
matched
case-control)
Sugarcane
cutters;
uninfected and
stages I and 3 of
a 3-stage clinical
gradient (light,
moderate,
severe) for
infected workers
94
(retrospective);
36
(prospective)
infection by S.
mansoni
Reduced
earnings
compared to
controls
Retrospective:
no significant
difference;
Prospective:
Stage III
31.9% to
38.4% less
productivity vs.
stage I
Idem 2
Blas 2006 Philippines Observational
study
Municipalities
with relatively
high endemicity
801 infection by S.
japonicum
Loss of working
capacity
Assumed loss:
25% (mild),
50%
(moderate),
75% (severe),
100% (very
severe)
Idem 2
Fenwick 1972 Tanzania Observational
study
Cane-cutters;
men (uninfected,
infected,
treated)
approx. 300 S. mansoni Mean bonus
earnings,
increase in
cane cut
3% significant
difference in
productivity
between
uninfected and
infected
workers; true
difference
might be 5%
Idem 2
Kamel 2002 Egypt Case vs.
control
Textile company
workers
(infected vs
healthy)
340 (170 vs
170)
infection by S.
haematobium;
S. mansoni
a) productivity
score
a) 1059 vs
1113 (non-
significant)
a) 4.8%
b) additional
hours/month
b) 26.5 vs 32.6
hours
(significant)
b) 18.7%
c) total
incentives/
month
c) 46.3 vs 56.2
incentives
(significant)
c) 17.6%
Leshem 2008 Tanzania Observational
study
Israeli travelers 27 Acute
schistosomiasis
# missed
workdays
Average 7.8
days
2.6%
Leslie 2011 Niger Cost
effectiveness
analysis
Schistosomiasis
control
programs
(school-based
vs community
distributed MDA)
484 infection by S.
haematobium
potential
economic gain
from adult
treatment
$4.30, equal to
3 days of labor
(based on
agricultural
day rate of
$1.40 in 2005)
or 2.3 days
(based on rate
of $1.90 in a
normal year)
1%
(Continued)
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A summary of the main features of the studies that investigated productivity loss due to tra-
choma quantitatively is shown in Table 6.
Of the studies we identified, none of them directly observed the extent of productivity loss
caused by trachoma in a population. The three studies that examined this topic made assump-
tions about productivity loss in order to calculate the costs. [53–55] These studies assumed a
productivity loss of either 60% or 100% for blindness and 24.5% for visual impairment and
these percentages were based on the disability weights that existed at the time of the studies.
Risk of bias
Sixty percent of the selected articles had a high overall risk of bias (26 articles of 42), mostly
due to detection bias (24 of 42 articles), selection bias (21 articles of 42), and attrition bias (10
of 42 articles). Twenty-two articles were rated as relevant, and of these studies, two-thirds (14/
21) had a high overall risk of bias, 2 had a low overall risk of bias and 6 had an unclear overall
risk. Only 6 articles had a low overall risk of bias, of which only 2 were relevant, and 9 had an
unclear summary rating, of which 6 were relevant (as described before). No particular trend
was observed, regarding over- or underestimation of results due to bias. For the complete risk
of bias assessment table, please refer to S3 Table.
Table 4. (Continued)
Author Year Country Study design Population Sample size Sequela Definition of
productivity
loss
Results Percentage
of annual
prod. loss 1
Umeh 2004 Nigeria Observational
study
315 households
from 4
communities
1763 Urinary
Schistosomiasis
Average # of
work-days lost
due to urinary
schistosomiasis
a) 4.7 days
(head of
household)
a) 1.5%
b) 27.7 (adult
male)
b) 9.2%
c) 17.6 (wife) c) 5.8%
d) 24.7 (adult
female)
d) 8.2%
e) 19.09
weighted
average
e) 6.3%
Wright 1972 Africa,
Mauritius,
Southwest
Asia,
Southeast
Asia,
America,
World
Economic
impact
assessment
various n/a infection by S.
haematobium;
S. mansoni; S.
japonicum
Reduced
productive
capacity
Assumed loss:
100%
(severe), 10%
(moderately
severe)
Idem 2
Wu 2002 China Case vs.
control
(matched)
Patients with
advanced S.
japonicum vs
healthy
individuals
48 cases, 56
controls
Advanced S.
japonicum
Average
workdays lost
Case vs.
control: 4.11
vs. 0.86 days
(p<0.01)
1%
n/a—not applicable; S. haematobium—Schistosoma haematobium; S. japonicum—Schistosoma japonicum; S. mansoni—Schistosoma mansoni, #—
number of
1. Translation into percentage of annual productivity loss assuming 300 working days a year
2. Percentage of annual productivity loss already calculated in the original publication
doi:10.1371/journal.pntd.0004397.t004
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Discussion
Neglected tropical diseases can have a profound effect on the health and economic livelihood
of the individuals suffering from them as well as that of their families. We examined what has
been published in the literature regarding the loss in productivity seen amongst patients with
the NTDs that are eligible for preventive chemotherapy: lymphatic filariasis, onchocerciasis,
schistosomiasis, soil-transmitted helminths (ascariasis, trichuriasis, and hookworm infection)
and trachoma. In general, our systematic literature review revealed that few studies have actu-
ally examined the degree of productivity loss related to these NTDs, which to some extent
Table 5. Description of studies investigating productivity loss due to soil-transmitted helminths.
Author Year Country Study design Population Sample
size
Sequela Definition of
productivity
loss
Results Percentage
of annual
prod. loss 1
Basta 1979 Indonesia Case vs
control
Rubber plantation
workers (male)
302 Anemia a) collection of
wet latex by
tappers
a) 18.7% more Idem 2
b) removal of
roots and weeds
b) 20% more Idem 2
c) physical
capacity test
(HST)
c) 15% higher
HST scores in
non-anemic group
Idem 2
Gilgen 2001 Bangladesh RCT of iron-
folic acid
supplement &
regular
deworming
Tea pluckers
(female)
randomized to
different
treatment arms
553 Anemia a) volume of
green leaves
plucked per day
(kg/pld)
a) 1.8 less kg
plucked (anemic
vs. non-anemic)
a) 6.3%
b) average
wages earned
per day
b) $1.1 less b) 4%
c) sick leave (#
days)
c) 0.3 days more c) 0.1%
d) absenteeism
(# days)
d) 0.9 days more d) 0.3%
Selvaratnam 2003 Sri Lanka Before-after Tea pluckers
(2500 m above
sea level)
(female)
304 Anemia Volume of
leaves plucked
(per increase in
hemoglobin of
1g/dL)
26% increase Idem 2
Wolgemuth 1982 Kenya Case vs
control
Road
construction
workers (male,
female)
47 Infection
/Anemia
Volume of earth
moved (m3/
hour)
6% loss; Hb
increase of 1.30 g/
dL associated with
a 5.6% increase in
productivity
Idem 2
Casey 2011 Vietnam Before-after
(CEA)
Women in
reproductive age
in rural area
349 Anemia Individual
productivity gain
after
improvement of
anemic state
5% in manual and
17% in heavy
occupation (used
values by Horton
and Ross 2003)
Idem 2
Tanner 2013 Bolivia Case vs
control
Indigenous group
of hunter-
horticulturalists
86 Infection Yield in
agricultural and
hunting/fishing
(24h period)
(uninfected 6.8 kg
vs. infected 4.4 kg;
nonsignificant)
35.29%
CEA—Cost effectiveness analysis; RCT—randomized controlled trial, #—number of
1. Translation into percentage of annual productivity loss assuming 300 working days a year
2. Percentage of annual productivity loss already calculated in the original publication
doi:10.1371/journal.pntd.0004397.t005
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might have been influenced by the focus on literature written in English. Table 7 shows a sum-
mary of the flowcharts for all PCT NTDs, which shows the relatively small numbers of articles
containing quantitative information on productivity loss related to PCT NTDs compared to
the number of the publications screened by title and abstract.
We also found large variation in the definition of productivity loss as well as the estimated
productivity loss as reflected in percentage productivity loss over a one-year period. This is not
surprising given the diversity in the methods chosen to quantify absolute and relative produc-
tivity loss, the many symptoms that these NTDs can cause, and the many different contexts of
the different countries and regions where these diseases are endemic.
Many of these studies were performed many years ago and involved very specific popula-
tions in specific countries. However, besides biological reasons, there are methodological rea-
sons for this variation. One explanation is simply random variation, where the results of two
studies with the very same study design simply differ due to chance. A more important issue
relates to the fact that studies varied in their approach when examining productivity loss. First
of all, studies varied in their selection of the study population. Many studies focused on workers
on large plantations, while others observed road workers, and the different studies were per-
formed in different settings and countries, which might differ in important ways from other
professions and other populations suffering from the same NTD elsewhere. The generalizabil-
ity of the results from one study to another population must therefore be carefully considered.
The second type of variation in study design relates to the choice of comparison group.
Most studies chose workers who did not have the NTD as the comparison group (only one,
Gyapong 1996, compared patients with lymphatic filariasis with patients with other febrile dis-
eases). The sometimes tacit assumption made with this comparison is that any difference in
productivity can be attributed to the NTD and its symptoms. However, the validity of this
Table 6. Description of studies investigating productivity loss due to trachoma.
Author Year Country Study
design
Population Sample
Size
Sequela Definition of productivity loss Productivity
loss 1
Frick 2001 The
Gambia
Model n/a n/a Low
vision
Based on disability weight (GBD, 1996) 24.5%
Frick 2003a Global Model n/a n/a a)
blindness
Based on disability weight (GBD, 1996) a) 60%
b) low
vision
Based on disability weight (GBD, 1996) b) 24.5%
Frick 2003b Global Model n/a n/a a)
blindness
Assumptions based on disability weights (GBD,
1996), also assumed that 10% of blind persons
required a caregiver who lost productivity completely
a) 60%/100%
b) low
vision
Assumptions based on disability weights (GBD,
1996), also assumed that 10% of blind persons
required a caregiver who lost productivity completely
b) 24.5%
n/a—not applicable
1. Percentage of annual productivity loss actually used in the original publication
doi:10.1371/journal.pntd.0004397.t006
Table 7. Summary of flowcharts for all PCT NTDs.
Lymphatic filariasis Onchocerciasis Schistosomiasis STH Trachoma
Papers screened on title and abstract 305 219 670 586 549
Assessed full text 72 57 26 72 22
Studies with quantitative info on productivity losses 13 10 10 6 3
doi:10.1371/journal.pntd.0004397.t007
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comparison can be questioned, certainly if no correction is made for background characteris-
tics such as age, sex, job experience, diet, height, and BMI (body mass index), which can affect
productivity. Fortunately, some but not all studies included these factors when analyzing and
reporting their results. Other studies did not compare two different populations but used a
before-after study design to see how much productivity improved after treatment. This
approach focuses directly on the productivity gain that can be achieved using available
treatments.
The third type of variation relates to the actual measure of productivity. Many studies used
the number of hours or days to quantify productivity. In contrast, some studies used other,
arguably more accurate, methods which involved examining the volumes that were actually
collected or processed per day (i.e. how many kilograms of tea were plucked per day). [49]
Some studies even used multiple outcomes to study productivity loss. Ultimately, one could
argue that the choice of outcome measure should be based on what a decision-maker considers
important. For example, an employer might be particularly interested in volume outcomes
since workers with an NTD who never miss a day at work may nevertheless be less productive
than other workers. Another point worth considering when measuring productivity loss is that
the adjustment of worker behavior and the associations between nutrition, body composition,
and work productivity may be more complex. Workers might adapt work pace or intensity,
allowing them to minimize the effects of poor health on work productivity. [47]
The fourth type of variation relates to the length of time that productivity loss is measured.
Most studies used a fixed length of time (e.g., year) when measuring productivity, also to
account for seasonality, which could also influence productivity along the year. In some
instances, however, the length of time was disease-based (e.g., length of an episode). This
approach may reveal that productivity loss is very high (>50%) if the symptoms are extreme,
but the impact of disease on productivity over a longer period (e.g., one year) may be small if
these episodes last just a few days and only occur a couple of times per year.
Other limitations of the studies are worth mentioning. Firstly, many studies did not check
for other concomitant NTDs prevalent in the same region. One possible reason for this could
be the assumption that the control group has the same risk to be affected by the non-investi-
gated disease as the case group. Secondly, measurement of productivity loss in working popula-
tions may lead to an underestimation of impact due to the ‘healthy worker effect’, since people
who had to stop working because of the disease are excluded from the study [38]. Thirdly.
most of the studies that diagnosed NTDs using stool examination took only one sample, which
resulted in a high probability of false negatives and a possible underestimation of productivity
loss due to the NTD. [56–58] Lastly, correction of hemoglobin levels for altitude or for smoking
status of the patients was not mentioned by any of the anemia studies, which could also lead to
an underestimation of the productivity loss. [59]
Based on the literature, the NTDs with the greatest impact on an individual’s productivity
loss are onchocerciasis and trachoma, because both of them can lead to blindness. The studies
of actual patients revealed an increased likelihood of stopping with work or a substantial
decrease in productivity. However, other studies simply assumed that productivity loss would
be high.
It is important to distinguish between productivity loss at an individual level from produc-
tivity loss at a population level. For example, while the individual productivity loss from an
NTD like STH may be much less than loss from another NTD like onchocerciasis, the overall
impact of STH at a population level may be greater than that of onchocerciasis as a result of its
higher prevalence. Therefore, what we consider important depends on the perspective we are
taking (either that of the individual or that of the population).
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The extent to which productivity is affected by diseases–in this case NTDs–can also help to
understand the economic burden of diseases for affected individuals, countries, regions, and
even globally. If we take the example of STH in India, around 50 million cases of hookworm
(in adults older than 15 years) would be expected in 2020 if the epidemiological situation in
1990 had continued unabated. If we assume an annual income of US$1333 (which equals the
annual income of an individual in the lowest GDP quintile in India in 2005) and an average
productivity loss due to hookworm anemia of 6%, we could estimate an economic burden from
productivity loss of roughly US$ 4 billion just in that one year. Obviously, the impact is much
more pronounced when other years or countries are considered. These estimates can help to
estimate the impact on productivity of achieving the targets described in the 2012 London Dec-
laration. [18]
Some recommendations regarding future studies of productivity loss can also be made. The
assessment of productivity loss secondary to NTDs should be further researched to enable a
better understanding of the economic burden it generates. Additional research is needed to
develop standard methods to describe absolute and relative productivity loss. However, this
will not be an easy task, given the diverse symptoms caused by these diseases and the variety of
countries and cultures where these diseases are endemic; with some NTDs such as lymphatic
filariasis, a distinction between treated and untreated patients will have to be made as well. As
described above, there are some factors that should be considered when designing future stud-
ies: the choice of the comparison group (preferably a comparable assuredly non-infected
group), the outcome measure assessing productivity (preferably quantitative), the length of the
assessment (not only during acute attacks, accounting for seasonal variation), and confounders
of the disease effect on the productivity/work performance (for instance nutrition, BMI, type of
work/profession). These elements should be transparently described and their (missing) values
discussed, to determine how much they might have influenced the results. In particular,
researchers should provide sufficiently detailed information to enable readers to assess the
quality and relevance of the study.
Conclusion
Various studies have examined productivity loss in patient populations having one of the five
most prevalent NTDs. While is clear that these diseases reduce productivity, the actual impact
depends on the type, severity and duration of the NTD as well as on the setting. Variation in esti-
mated productivity loss between and within diseases is caused by differences in the different defi-
nition of productivity loss, research methods and setting. It is therefore important to examine the
literature carefully to understand what was actually observed in order to draw conclusions about
the generalizability of the studies. Since productivity loss is an important aspect of the burden of
diseases, further research on better estimates of the magnitude of the productivity loss caused by
NTDs would enable a more complete picture of their economic burden to individuals, countries,
and globally, adding an additional persuasive argument in favor of their control.
This review already contributes to a better perception of the magnitude of the effect of an
NTD on people’s working and economic situation, and can already offer additional arguments
in favor of controlling and eliminating them. However, there is still much room for further
research in this field to improve the understanding on NTDs’ effects on individuals’ productiv-
ity loss.
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